Faculty Opinions recommendation of Perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysis.

Purpose The purpose of the study is to investigate the impact of economic and financial crimes on the economies of emerging and developing countries. Design/methodology/approach Preferred Reporting Items for Systematic review and Meta-Analysis (PRISMA) guidelines and meta-analysis of economics research reporting guidelines were used to conduct a quantitative synthesis of empirical evidence on the impact of economic and financial crimes in developing and emerging countries. Findings A total of 103 studies were searched, out of which 6 met the selection/eligibility criteria of this systematic review. The six selected studies indicated that economic and financial crimes have a negative impact in emerging and developing countries. Originality/value To the best knowledge of the authors, no published systematic review of the impact of economic and financial crimes in developing countries has been conducted to date.

Download Full-text

Effect of Corticosteroid Therapy on Influenza-Related Mortality: A Systematic Review and Meta-analysis

The Journal of Infectious Diseases ◽

10.1093/infdis/jiu645 ◽

2014 ◽

Vol 212 (2) ◽

pp. 183-194 ◽

Cited By ~ 40

Author(s):

Chamira Rodrigo ◽

Jo Leonardi-Bee ◽

Jonathan S. Nguyen-Van-Tam ◽

Wei Shen Lim

Keyword(s):

Systematic Review ◽

Corticosteroid Therapy ◽

Meta Analysis ◽

Related Mortality

Download Full-text

Antifungal Prophylaxis in Cancer Patients After Chemotherapy or Hematopoietic Stem-Cell Transplantation: Systematic Review and Meta-Analysis

Journal of Clinical Oncology ◽

10.1200/jco.2007.12.3851 ◽

2007 ◽

Vol 25 (34) ◽

pp. 5471-5489 ◽

Cited By ~ 191

Author(s):

Eyal Robenshtok ◽

Anat Gafter-Gvili ◽

Elad Goldberg ◽

Miriam Weinberger ◽

Moshe Yeshurun ◽

...

Keyword(s):

Systematic Review ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Adverse Events ◽

Cancer Patients ◽

Meta Analysis ◽

Antifungal Prophylaxis ◽

Hematopoietic Stem ◽

All Cause Mortality ◽

Related Mortality

Purpose To evaluate the effect of antifungal prophylaxis on all-cause mortality as primary outcome, invasive fungal infections (IFIs), and adverse events. Many studies have evaluated the role of antifungal prophylaxis in cancer patients, with inconsistent conclusions. Methods We performed a systematic review and meta-analysis of randomized, controlled trials comparing systemic antifungals with placebo, no intervention, or other antifungal agents for prophylaxis in cancer patients after chemotherapy. The Cochrane Library, MEDLINE, conference proceedings, and references were searched. Two reviewers independently appraised the quality of trials and extracted data. Results Sixty-four trials met inclusion criteria. Antifungal prophylaxis decreased all-cause mortality significantly at end of follow-up compared with placebo, no treatment, or nonsystemic antifungals (relative risk [RR], 0.84; 95% CI, 0.74 to 0.95). In allogeneic hematopoietic stem-cell transplantation (HSCT) recipients, prophylaxis reduced all-cause mortality (RR, 0.62; 95% CI, 0.45 to 0.85), fungal-related mortality, and documented IFI. In acute leukemia patients, there was a significant reduction in fungal-related mortality and documented IFI, whereas the difference in mortality was only borderline significant (RR, 0.88; 95% CI, 0.74 to 1.06). Prophylaxis with itraconazole suspension reduced documented IFI when compared with fluconazole, with no difference in survival, and at the cost of more adverse events. On the basis of two studies, posaconazole prophylaxis reduced all-cause mortality (RR, 0.74; 95% CI, 0.56 to 0.98), fungal-related mortality, and IFI when compared with fluconazole. Conclusion Antifungal prophylaxis decreases all-cause mortality significantly in patients after chemotherapy. Antifungal prophylaxis should be administered to patients undergoing allogeneic HSCT, and should probably be administered to high-risk acute leukemia patients.

Download Full-text

Role of maternity waiting homes in the reduction of maternal death and stillbirth in developing countries and its contribution for maternal death reduction in Ethiopia: a systematic review and meta-analysis

BMC Health Services Research ◽

10.1186/s12913-018-3559-y ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 11

Author(s):

Tegene Legese Dadi ◽

Bayu Begashaw Bekele ◽

Habtamu Kebebe Kasaye ◽

Tadesse Nigussie

Keyword(s):

Systematic Review ◽

Developing Countries ◽

Maternal Death ◽

Meta Analysis ◽

Maternity Waiting Homes

Download Full-text

Active pulmonary tuberculosis and coronavirus disease 2019: A systematic review and meta-analysis

PLoS ONE ◽

10.1371/journal.pone.0259006 ◽

2021 ◽

Vol 16 (10) ◽

pp. e0259006

Author(s):

Ashutosh Nath Aggarwal ◽

Ritesh Agarwal ◽

Sahajal Dhooria ◽

Kuruswamy Thurai Prasad ◽

Inderpaul Singh Sehgal ◽

...

Keyword(s):

Systematic Review ◽

Pulmonary Tuberculosis ◽

Patient Outcomes ◽

Meta Analysis ◽

Severe Disease ◽

Random Effects Models ◽

Tuberculosis Patients ◽

Active Pulmonary Tuberculosis ◽

Risk Of Mortality ◽

Related Mortality

Objective The proportion of COVID-19 patients having active pulmonary tuberculosis, and its impact on COVID-19 related patient outcomes, is not clear. We conducted this systematic review to evaluate the proportion of patients with active pulmonary tuberculosis among COVID-19 patients, and to assess if comorbid pulmonary tuberculosis worsens clinical outcomes in these patients. Methods We queried the PubMed and Embase databases for studies providing data on (a) proportion of COVID-19 patients with active pulmonary tuberculosis or (b) severe disease, hospitalization, or mortality among COVID-19 patients with and without active pulmonary tuberculosis. We calculated the proportion of tuberculosis patients, and the relative risk (RR) for each reported outcome of interest. We used random-effects models to summarize our data. Results We retrieved 3,375 citations, and included 43 studies, in our review. The pooled estimate for proportion of active pulmonary tuberculosis was 1.07% (95% CI 0.81%-1.36%). COVID-19 patients with tuberculosis had a higher risk of mortality (summary RR 1.93, 95% CI 1.56–2.39, from 17 studies) and for severe COVID-19 disease (summary RR 1.46, 95% CI 1.05–2.02, from 20 studies), but not for hospitalization (summary RR 1.86, 95% CI 0.91–3.81, from four studies), as compared to COVID-19 patients without tuberculosis. Conclusion Active pulmonary tuberculosis is relatively common among COVID-19 patients and increases the risk of severe COVID-19 and COVID-19-related mortality.

Download Full-text